Home / Biotechnology / Global Drug Discovery Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Global Drug Discovery Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Published: Dec 2017 | Published By: Acute Market Research

Drug Discovery Technologies Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global drug discovery technologies market was valued at US$ 59.6 Bn in 2016, expanding at a CAGR of 12.1%.

Market Insights
Drug discovery is a complex process involving multiple stages and requiring extensive time and resources in identification of drug compound and validation for the specific disease treatment. As per the sequential orders, phases of drug discovery are selection and validation of targets, finding out hit, optimization of lead and pharmacological profiling. Funding from governments and pharmaceutical manufacturers helps to carry out drug discovery research in academic, pharmaceutical or biotechnology research laboratories.
Chronic diseases such as heart disease, diabetes, cancer, stroke, chronic respiratory disease are estimated to be the leading cause of deaths worldwide; as per the data of the World Health Organization (WHO), 60% of deaths are caused by chronic diseases. The drug discovery technologies market is majorly influenced by the increasing number of acute and chronic disease worldwide. The field of drug discovery is witnessing major developments since the trend in disease cure has shifted towards large molecule proteins and biopharmaceuticals from small chemical compounds. Recent inclination towards precision medicine and related research has significantly driven the drug discovery technologies market. Implementation of artificial intelligence tools like Watson IBM for drug discovery is expected to fuel the market growth by speeding up the research and leading to new insights. Collaboration between Pfizer and Watson IBM for immune-oncology drug discovery and tie-up between GlaxoSmithKline and Exscientia for identification of drugs molecule to cure up to 10 different disease are expected to bring out promising therapeutics in treatment. Recently, Sirenas received grant of US $1.68 million from the Bill & Melinda Gates Foundation to enhance drug discovery utilizing computational technology called ATLANTIS. Such funding has a positive impact on the drug discovery technologies market growth by driving the overall research. Merger activities of pharmaceutical companies has brought about increasing R&D productivity as a result of combining knowledge and supporting research capabilities. Rising popularity of drug repositioning using bioinformatics also boosted the growth of drug discovery technologies market.

This market gets affected by the huge failure rate of drugs at clinical trial due to inadequate target validation at basic research, absence of thorough preclinical testing of drugs in modern model frameworks, poor communication and coordination among researchers, drug developers and clinicians; and absence of solid responder speculations preceding entering the clinic and all through the procedure of clinical development. The future drug discovery technologies market is expected to witness positive growth as few organizations have started working to overcome the aforementioned barriers.
On the basis of technology type, high throughput screening is widely used in research with increasing demand for automated and computerized facilities. On the regional basis, in the year 2016, North America dominated the drug discovery technologies market followed by Europe. The increasing investment of U.S. based foundations in drug discovery and increasing drug approval by the U.S. Food and Drug Administration (USFDA) have contributed immense growth to the market.

Market Competition Assessment:
The key industry players of drug discovery technologies market include Abbott Laboratories, Inc., Novartis AG, Eli Lily, Affymetrix Inc, AstraZeneca plc., Boehringer Ingelheim, Inc., Bayer Healthcare AG, GlaxoSmithKline LLC., Pfizer Inc., Sanofi, Albany Molecular Research Inc., Luminex Corporation, and other notable players.

Key Market Movements:
• Advanced technologies such as artificial intelligence platforms to accelerate overall drug discovery process and to provide new insights
• Oncology drug discovery collaboration between pharmaceutical companies like Vernalis plc. and Daiichi Sankyo and tie-up of Cancer Research UK with Celgene Corporation are expected to strengthen the research for anticancer treatment
• Initiatives have been taking in drug discovery area like Lab 150 in Canada, to bridge research, translation and commercialization which is anticipated to further augment successful drug development process

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Drug Discovery Technologies Market Portraiture
2.1.1. Global Drug Discovery Technologies Market, by Type, 2016 (US$ Mn)
2.1.2. Global Drug Discovery Technologies Market, by Geography, 2016 vs. 2025 (Value %)

Chapter 3. Drug Discovery Technologies Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drug Discovery Technologies: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Drug Discovery Technologies Market, by Type, 2016
4.2. High Throughput Screening
4.3. Biochips
4.4. Bioinformatics
4.5. Pharmacogenomics and Pharmacogenetics
4.6. Combinatorial Chemistry
4.7. Nanotechnology
4.8. Spectroscopy
4.9. Metabolomics
4.10. Others (RNAi, Proteomics, Epigenetics, Chromatography)

Chapter 5. Global Drug Discovery Technologies Market, by Geography, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. North America Drug Discovery Technologies Market Analysis, 2015 – 2025
5.2.1. North America Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
5.2.2. North America Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Drug Discovery Technologies Market Analysis, 2015 – 2025
5.3.1. Europe Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
5.3.2. Europe Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Drug Discovery Technologies Market Analysis, 2015 – 2025
5.4.1. Asia Pacific Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
5.4.2. Asia Pacific Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. India
5.4.2.4. Rest of APAC
5.5. Latin America Drug Discovery Technologies Market Analysis, 2015 – 2025
5.5.1. Latin America Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
5.5.2. Latin America Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Drug Discovery Technologies Market Analysis, 2015 – 2025
5.6.1. MEA Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
5.6.2. MEA Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1.1. Business Description
6.1.1.2. Financial Information (Subject to data availability)
6.1.1.3. Product Portfolio
6.1.1.4. Key Developments
6.2. Affymetrix Inc.
6.3. Albany Molecular Research Inc.
6.4. AstraZeneca plc.
6.5. Bayer Healthcare AG
6.6. Boehringer Ingelheim, Inc.
6.7. Eli Lily
6.8. GlaxoSmithKline LLC.
6.9. Luminex Corporation
6.10. Novartis AG
6.11. Pfizer Inc.
6.12. Sanofi

TABLE 1 Global Drug Discovery Technologies Market Portraiture
TABLE 2 Global Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Drug Discovery Technologies Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn
TABLE 10 Latin America Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 11 Latin America Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn
TABLE 12 Middle East and Africa Drug Discovery Technologies Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 13 Middle East and Africa Drug Discovery Technologies Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Affymetrix Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Albany Molecular Research Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Bayer Healthcare AG.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Boehringer Ingelheim, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Eli Lily: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 GlaxoSmithKline LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Luminex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Sanofi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

FIG. 1 Drug Discovery Technologies: Market Segmentation
FIG. 2 Global Drug Discovery Technologies Market Share, by Type, 2016 (US$ Mn)
FIG. 3 Global Drug Discovery Technologies Market, by Geography, 2016 vs. 2025 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global High Throughput Screening Market, 2015 – 2025 (US$ Mn)
FIG. 7 Global Biochips Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Bioinformatics Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Pharmacogenomics and Pharmacogenetics Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Combinatorial Chemistry Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Nanotechnology Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Bioanalytical Instruments Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Metabolomics Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Other Technologies in Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 15 U.S. Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 16 Canada Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 17 U.K. Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 18 Germany Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 19 Rest Of Europe Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 20 Japan Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 21 China Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 22 India Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest Of Asia Pacific Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 24 Brazil Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 25 Mexico Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest Of Latin America Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 27 GCC Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest Of Middle East And Africa Drug Discovery Technologies Market, 2015 – 2025 (US$ Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +